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Rat erythrocytes fuse when treated with the membrane mobility agent, 2-(2-methoxyethoxy)ethyl-c&-8-(2- 
octylcyclopropyl)octanoate (A&) and Ca*+, whereas human cells do not. Membrane proteolysis promoted 
by calpain is required for rat cell fusion [( 1986) Eur. J. Biochem., in press]. Human calpain induced a selec- 
tive proteolysis in both the human and rat erythrocyte ghosts (mainly band 4.1 in the human, band 4.1 
and band 3 in the rat cell) and rendered them fusible. Calpastatin (calpain inhibitor) prevented A$-induced 
fusion in both ghosts, via inhibition of proteolysis. The human erythrocyte has excess calpastatin and resists 
A&-promoted fusion. A regulatory role of calpastatin in membrane fusion is thus indicated. 
Membrane fusion Membrane proteolysis Calpainlcalpastatin Erythrocyte membrane 
Membrane mobility agent Fusogenic agent 
1. INTRODUCTION 
Membrane fusion is important for diverse 
cellular processes such as fertilization, myoblast 
fusion and virus entry into cells [l-3]. It is induced 
experimentally by certain viruses and chemical 
agents [l-6]. The membrane mobility agent, 2-(2- 
methoxyethoxy)ethyl - cis - 8 - (2 - octylcyclopropyl) -
octanoate (AK) is an inducer of membrane fusion 
and has been useful in defining stages and factors 
involved in this process [6,7]. 
We have previously found differences among 
erythrocytes of various species in the response to 
A2C [8]. Rat erythrocytes fuse readily when treated 
with A2C and Ca’+, but human cells do not [8,9]. 
We have shown fusibility to be correlated with 
Ca’+-induced membrane protein degradation, 
which occurs in the rat erythrocyte but not in the 
human cell [9]. Using rat erythrocyte ghosts, we 
have demonstrated that the membrane protein 
degradation required for rat erythrocyte fusion is 
due to the Ca2+-activated, cytoplasmic thiol- 
protease, calpain I [9,10]. 
Calpains are widely distributed in avian and 
mammalian tissues, including erythrocytes [111. A 
calpain inhibitor, calpastatin, has also been found 
in a variety of cells in widely varying amounts 
[ 11,121. Calpastatin activity has been identified 
through the inhibition of calpain-induced 
hydrolysis of several soluble proteins, such as ca- 
sein and globin [ 1 l-131. Thus defined, calpain ac- 
tivity in rat erythrocytes is greater than calpastatin 
activity, whereas in human erythrocytes 
calpastatin activity is greater than that of calpain 
[Ill. 
In view of the differences noted between rat and 
human erythrocyte fusibility [f&10], we have in- 
vestigated the effect of calpastatin on A2C-induced 
membrane fusion. We show that calpastatin 
prevents fusion of human and of rat erythrocyte 
membranes through inhibition of calpain- 
dependent membrane proteolysis. An activity of 
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calpastatin on a cellular level is thus demonstrated were eluted with a linear gradient of O-250 mM 
and a regulatory role in membrane fusion events is NaCl. The pooled active fractions were 
indicated. lyophilized. 
2. MATERIALS AND METHODS 
2.1. Erythrocyte ghosts 
Heparinized blood from healthy humans and 
rats (Charles River derived rats) was centrifuged, 
the plasma and buffy coat removed, and the 
erythrocytes washed with 150 mM NaCl. 
Hemoglobin-free ghosts were prepared by 
hemolyzing washed erythrocytes in 5mM 
phosphate buffer (pH 8.2), followed by washing 
with 10 mM NaCl. 
2.2. Calpain and calpastatin 
Human erythrocytes were hemolyzed in 12 vols 
of 5 mM Tris-HCI (pH 7.4), 1.0 mM EGTA and 
0.5 mM dithiothreitol (DTT) (buffer A). 
Membrane-free hemolysate (obtained by cen- 
trifugation of the lyzed cells at 40000 x g, for 
30 min) was used for the isolation of calpain and 
calpastatin according to [11,12] with slight 
modifications. A DEAE-cellulose (Sigma, DE-52) 
column was prewashed with 50 mM NaCl/buffer 
A. After loading of the column with the 
hemolysate containing 50 mM NaCl, the column 
was washed with 50 mM NaCl/buffer A until free 
of hemoglobin. A fraction known to contain cal- 
pain and calpastatin was then eluted with 150 mM 
NaCl/buffer A [12]. This fraction was dialyzed 
against 0.1 mM EGTA, lyophilized, resuspended 
in a small volume of 20 mM Tris-HCl (pH 7.4), 
0.1 mM EGTA and 0.5 mM DTT (buffer B) and 
centrifuged at 40000 x g to clarify the solution. 
The concentrated fraction was loaded on an 
Ultrogel AcA 34 (LKB, Sweden) and fractions 
eluted with buffer B. Aliquots were analyzed for 
calpain activity, using casein as substrate [111. The 
fractions containing calpain activity were pooled, 
lyophilized and resuspended in buffer B. For fur- 
ther purification of calpain, the active fraction was 
chromatographed on a Blue Sepharose CL-6B col- 
umn, prewashed with 50 mM NaWbuffer B. 
Fractions were eluted with 1.0 M urea/buffer B. 
Fractions containing calpain activity were pooled 
and dialyzed with buffer B and loaded on DEAE 
Bio-Gel A, prewashed with buffer B. Fractions 
For the determination of calpastatin activity, ali- 
quots from the Ultrogel column fractions were 
heated at 100°C for 15 min to destroy calpain ac- 
tivity and centrifuged. Supernatant was added to a 
calpain-containing fraction and the decrease in cal- 
pain activity determined [ 11,121. Fractions con- 
taining calpastatin were pooled and further 
purified by rechromatography on a DE-52 column. 
After sample loading, the DE-52 column was 
washed with 80 mM NaCl/buffer B, followed by 
100 mM NaWbuffer B for the elution of 
calpastatin. The fractions containing calpastatin 
were pooled, dialyzed, lyophilized and resuspend- 
ed in buffer B. This fraction was heated as above, 
centrifuged and supernatant used as calpastatin 
solution. Aliquots of calpain and calpastatin were 
analyzed by SDS-acrylamide gel electrophoresis 
Vll. 
2.3. Membrane proteolysis and fusion 
Ghosts were suspended in buffer containing 
135 mM NaCl, 10 mM Tris-HCl (pH 7.4), 0.1 mM 
EGTA, 0.5 mM DTT, 1.0 mM CaClz and 
40 mg/ml dextran (T-70, Pharmacia) (buffer C). 
Ghost suspensions were incubated with a solution 
of calpain or calpain and calpastatin, centrifuged, 
resuspended in buffer C and incubated with AzC 
[9]. Aliquots were examined microscopically for 
fusion [9]. Ghosts were then mixed with 5 mM 
EDTA, centrifuged, solubilized and analyzed by 
SDS-acrylamide gel electrophoresis [9]. 
3. RESULTS 
Calpain and calpastatin, derived from human 
erythrocytes, were analyzed in fractions eluted 
from the Ultrogel AcA 34 column. Calpain activity 
was eluted at a position of about 1 lo-120 kDa, 
and calpastatin at about 240-280 kDa (fig.lA). 
Calpain was further purified on Blue Sepharose 
CLdB (not shown) followed by DEAE Bio-Gel A 
(fig.lB). Calpastatin was further purified on a 
DE-52 column (not shown). Electrophoresis of the 
calpain-containing fraction on SDS-acrylamide 
showed bands of 80 and 30 kDa and that of 
calpastatin showed a band of 70 kDa (fig.lC). The 
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Fig. 1. (A) Elution profile of calpain and calpastatin on a column of Ultrogel AcA 34. Hemolysate from 120 ml of 
erythrocytes was first eluted from a DE-52 column, then loaded on the Ultrogel column (see section 2). Fractions of 
1.4 ml were collected. Protein (AZSO) refers to the absorbance of eluted fractions at 280 nm, for the estimation of protein 
concentration. Activity (4750) refers to a change in absorbance at 750 nm. For calpain, one unit of activity corresponds 
to an increase of 1.0 A unit at 750 nm after 30 min incubation of casein and calpain, as defined by Hatanaka et al. 
[ 111. For calpastatin, one unit of activity corresponds to a decrease of 1 .O A unit (i.e. a decrease of one unit of calpain 
activity) at 750 nm when calpastatin is added to the calpain-containing fraction [11,12]. (B) Elution profile of calpain 
chromatographed on DEAE Bio-Gel A (fractions and units as in A). (C) SDS-polyacrylamide gel electrophoretic 
patterns of purified calpain and calpastatin. 
chromatographic behavidr of the active fractions 
and the electrophoretic analysis are in agreement 
with the properties reported for calpain I and 
calpastatin [ 11,121. 
Human erythrocyte ghosts were incubated with 
DTT, Ca2+ and calpain, with or without 
calpastatin, followed by A2C, as described in sec- 
tion 2. Ghosts incubated without calpain did not 
fuse when treated with A2C (fig.ZA). Czdpain- 
treated ghosts fused upon the addition of A2C to 
yield multicellular bodies (fig.ZB). In contrast, 
calpain- and calpastatin-treated ghosts did not fuse 
upon the addition of A2C (fig.ZC). Similar inhibi- 
tion of fusion was obtained by leupeptin, whereas 
fusion did occur in the presence of 
phenylmethylsulphonyl f uoride (not shown). Rat 
erythrocyte ghosts behaved in a similar way. 
Ghosts pretreated with calpain fused upon the ad- 
dition of AIC, whereas ghosts pretreated with cal- 
pain and calpastatin did not fuse (not shown). 
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Fig.2. Micrographs showing fusing and non-fusing human erythrocyte ghosts. Calpain or calpain and calpastatin were 
first incubated at 30°C for 20 min, then added to ghost suspensions in buffer C (8 units calpain and 15 units 
calpastatin/ml of 4% ghost suspension, containing 0.2 mg membrane protein). Ghost suspensions were then incubated 
at 37°C for 40 min, centrifuged, resuspended in buffer C and mixed with half a volume of A2C suspension (prepared 
by sonication of 0.5 ,~l of AK/ml 150 mM NaCl for about 30 s [6]). AZC-ghost suspensions were reincubated at 37’C. 
Aliquots were photographed after 60 min of incubation. Ghosts were incubated without calpain (A), with calpain (B), 
with calpain and calpastatin (C). 
Electrophoretic profiles of proteins, isolated 
from human erythrocyte ghosts treated with AS, 
are shown in fig.3. The profile of proteins from 
A 8 C D 
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control, non-fusing ghosts (incubated in buffer 
without calpain, followed by A&) is shown in 
fig.3A. In fusing ghosts (calpain-treated, followed 
by A2C) band 4.1 disappeared, with slight changes 
in spectrin bands 1,2 and in band 3, accompanied 
by the appearance of bands of lower molecular 
masses (fig.3B). In non-fusing ghosts (calpain- and 
calpastatin-treated, or calpain- and leupeptin- 
treated, followed by AK) the profiles were similar 
to that of the control shown in fig.3A, i.e. 4.1 re- 
mained and no changes were visible in bands 1, 2 
and 3 (fig.3C,D). 
Ghosts incubated with DTT, Ca2+ and calpain, 
but without AK, underwent proteolysis similar to 
that shown in fig.3B, but did not fuse (not shown). 
A more extensive proteolysis was achieved by 
longer incubation of the human erythrocyte ghosts 
Fig.3. SDS-polyacrylamide gel electrophoretic patterns 
of membrane proteins isolated from fusing and non- 
fusing human erythrocyte ghosts. Ghost suspensions 
(4% in buffer C) were incubated at 37°C for 40 min, 
centrifuged and further treated with A&, as described in 
fig.2. Ghosts incubated without calpain (A), with 8 units 
calpain/ml ghost suspension (B), with 8 units calpain 
and 15 units calpastatin (C), with 8 units calpain and 
1.0 mM leupeptin (D). 
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Fig.4. SDS-polyacrylamide gel electrophoretic patterns 
of membrane proteins isolated from calpain-treated 
human erythrocyte ghosts. Ghost suspensions (4% in 
buffer C) were incubated at 37’C for 120 min. with 8 
units calpain and MgClz (instead of CaClz)/ml ghost 
suspension (A), 8 units calpain (B), 16 units calpain (C), 
8 units calpain and 1.0 mM leupeptin (D). Calpain 1 
refers to 8 units calpain/ml ghost suspension and calpain 
2 to 16 units calpain/ml ghost suspension. 
with the same or higher amounts of calpain 
(fig.4B,C). Under these conditions, the changes in 
bands 1, 2 and 3 and the appearance of bands of 
lower molecular masses were more noticeable than 
those shown in fig.3B, in addition to the disap- 
pearance of band 4.1. When Mg2+ was ubstituted 
for Ca2+ or when calpain activity was inhibited, no 
changes were observed in bands 1, 2, 3 and 4.1 
(fig.4A,D). The ghosts undergoing extensive pro- 
teolysis did not fuse in the absence of A2C and 
usually disintegrated to small vesicles upon treat- 
ment with A2C. 
4. DISCUSSION 
Human calpain used here induced protein 
degradation in both human and rat erythrocyte 
membranes and rendered them fusible. Alterations 
in membrane proteins, however, were not identical 
in the human and rat erythrocyte. Calpain induced 
degradation of band 4.1 in both the human and the 
rat erythrocyte. In the rat, in addition to band 4.1 
degradation, calpain also induced limited pro- 
teolysis of band 3, the degradation of both being 
associated with fusibility of rat erythrocyte ghosts 
(unpublished). This may be due to differences in 
membrane structure and/or to differences in target 
proteins and in substrate specificity. The fact that 
both membranes were rendered fusible indicates 
that the same consequence may be achieved in 
membranes having dissimilar structure and 
substrate specificity. The protein(s) and the amino 
acid sequences ubject to attack by the human and 
rat enzymes are currently under study. 
We have previously found that rat erythrocytes 
fuse when treated with A2C and Ca’+, whereas 
In conclusion, the human erythrocyte membrane 
is capable of undergoing fusion. The lack of 
human cells do not. Rat erythrocyte ghosts, 
pretreated with calpain and Ca’+, undergo fusion 
upon the addition of A2C [8-lo]. Here, we show 
that human erythrocyte ghosts can also be induced 
to fuse by A2C, provided they are pretreated with 
Ca2+ and calpain, and are free of calpastatin. 
Calpains have been shown to degrade certain 
cellular, membrane and cytoskeletal proteins 
[l l-191. Neither the nature of calpastatin activity 
towards cellular constituents nor the cellular roles 
of calpastatin are known. Calpastatin is shown 
here to inhibit calpain-induced membrane pro- 
teolysis and prevent AzC-induced membrane fu- 
sion in both human and rat erythrocyte ghosts. 
CaIpastatin may thus have a regulatory role in the 
function of membranes via modulation of calpain- 
induced proteolysis of membranes and/or 
cytoskeletal proteins. 
Membrane proteolysis is necessary, but not suf- 
ficient by itself to induce fusion. The present 
results point to a selective and limited proteolysis, 
i.e. mainly degradation of band 4.1, as prerequisite 
for AK-induced fusion [though partial proteolysis 
of band 2.1 may also be involved (preliminary 
observations)]. Such proteolysis may free re- 
strained membrane components and render them 
potentially mobile. The actual mobility must be 
enhanced with a reagent such as A2C, creating pro- 
tein particle-poor, fusion-potent areas [8,9]. 
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fusibility is not because of resistant membrane 
structure, but is due to the activity of the protease 
inhibitor, calpastatin. Cells are known to vary ixr 
fusibility [20,21]. Differences in the balance of 
protease and protease inhibitor activity may ac- 
count for some cases of poor fusibility. 
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